| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/24/2004 | EP1399150A1 Vitamin c compositions |
| 03/24/2004 | EP1399149A2 Taxane prodrugs |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1399021A1 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide |
| 03/24/2004 | EP1349558A4 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1296700A4 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1200399B1 Vitamin d3 analogs |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1097150B1 Imidazolyl derivatives |
| 03/24/2004 | EP1033981B1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 03/24/2004 | EP1014990A4 Method of treating a tumor |
| 03/24/2004 | EP0986393B1 The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| 03/24/2004 | EP0873332B1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy |
| 03/24/2004 | EP0869970B1 Endothelial cell proliferation inhibitor and its use |
| 03/24/2004 | EP0850319B1 Method for modulating cell apoptosis |
| 03/24/2004 | EP0819432B1 Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen |
| 03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
| 03/24/2004 | EP0795015B1 Plasmids suitable for il-2 expression |
| 03/24/2004 | EP0777670B1 Substituted camptothecin derivatives and process for their preparation |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 03/24/2004 | CN1484646A Mikanolide derivatives their preparation and therapeutic uses |
| 03/24/2004 | CN1484639A Geldanamycin derivative and method of treating cancer same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484533A Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis for the treatment and prevention of |
| 03/24/2004 | CN1484532A Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1484525A Combinations of drugs (E. G chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 03/24/2004 | CN1483820A Carcinoma of esophagus related gene-2 and use of coding protein thereof |
| 03/24/2004 | CN1483716A Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 03/24/2004 | CN1483477A Vaccin composition, preparation method and use thereof |
| 03/24/2004 | CN1483468A Huaaidan pellet medicine for treating cancer and preparation method thereof |
| 03/24/2004 | CN1483444A Formula of rehmannia root effervescence preparation and process for preparing same |
| 03/24/2004 | CN1483425A Traditional Chinese medicine for treating cancer |
| 03/24/2004 | CN1483423A Traditional Chinese medicine for treating cancer and preparation method thereof |
| 03/24/2004 | CN1483405A Aqueous injection of curcuma oil extract and preparation process and use |
| 03/24/2004 | CN1142927C Chalcone coumarins |
| 03/24/2004 | CN1142923C 12,13-modified epothilone derivatives |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142919C Quinazoline derivatives as antitumor agents |
| 03/24/2004 | CN1142774C Method and pharmaceutical preparations for reducing the activity of cells |
| 03/23/2004 | WO2004080458A1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710195 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 03/23/2004 | US6710191 9β-hydroxytetracyclic taxanes |
| 03/23/2004 | US6710172 Tumor antigens and CTL clones isolated by a novel procedure |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710065 Benzimidazole derivatives and their use for the treatment of cancer or a viral infection |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710052 Anticancer agents |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710047 Phthalazines with angiogenesis inhibiting activity |
| 03/23/2004 | US6710039 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharamceutical compositions containing these compounds |
| 03/23/2004 | US6710029 Dehydrodidemnin B |
| 03/23/2004 | US6709679 Antineoplastic conjugates of transferin, albumin and polyethylene glycol |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | US6709651 Administering peptidase; substance p antagonist; central nervous system disorders |
| 03/23/2004 | US6709379 Implant with cavities containing therapeutic agents |
| 03/23/2004 | CA2519037A1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/20/2004 | CA2406504A1 Method of treating resistant tumors |
| 03/18/2004 | WO2004022768A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022751A1 Cnidarian cytotoxin gene and its expression and application |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022699A2 Liquid stable composition of oxazaphosphorine with mesna |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022562A1 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| 03/18/2004 | WO2004022560A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/18/2004 | WO2004022559A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/18/2004 | WO2004022554A1 Quinazolinone derivatives |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022163A1 Neoadjuvant treatment of breast cancer |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022099A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 03/18/2004 | WO2004022093A1 Whole bacterial cells as immune modulator |
| 03/18/2004 | WO2004022090A1 A method of modulating endothelial cell activity |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022062A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/18/2004 | WO2004022059A2 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 03/18/2004 | WO2004022056A1 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 03/18/2004 | WO2004022044A1 Use of a combination of a taxane with dppe for the treatment of cancer |
| 03/18/2004 | WO2004022040A2 Treatment of metastatic breast cancer with anthracyclines, taxanes and an histamine antagonist |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |